Company: BUDZ
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001096906-25-000350
Chunk: 87

Company: WEED, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 87
---
As a smaller reporting company
we are not required to provide a statement of risk factors. However, we believe this information may be valuable to our shareholders.
We reserve the right to not provide risk factors in our future filings. Our primary risk factors and other considerations include:

We have a limited
operating history and historical financial information upon which you may evaluate our performance.

You should consider, among
other factors, our prospects for success in light of the risks and uncertainties encountered by companies that, like us, are in their
early stages of development. We may not successfully address these risks and uncertainties or successfully complete our studies and/or
implement our existing and new products. If we fail to do so, it could materially harm our business and impair the value of our common
stock. Even if we accomplish these objectives, we may not generate the positive cash flows or profits we anticipate in the future. We
were incorporated in the State of Arizona on August 20, 1999. From 2005 until 2015, we were an exploration stage mineral exploration company
that owned a number of unpatented mining claims and Arizona State Land Department claims. On November 26, 2014, our Board of Directors
approved the redomestication of our company from Arizona to Nevada and we shifted our business focus to a company concentrating on the
development and application of cannabis-derived compounds for the treatment of human disease. Although (i) on November 22, 2021, we completed
our acquisition of the Sugar Hill Golf course property for possible use in a planned entry into the hemp and infused beverage market,
and (ii) our subsidiary, Sangre, has begun its planned five-year Cannabis Genomic Study to complete a global genomic classification of
the Cannabis plant genus, we need substantial funding to enter the hemp and infused beverage industry and for the completion of the Cannabis
Genomic Study both of which are likely years away. Unanticipated problems, expenses and delays are frequently encountered in establishing
a new business, conducting research, and developing new products. These include, but are not limited to, inadequate funding, unforeseen
research issues, lack of consumer acceptance, competition, product development, and inadequate sales and marketing. The failure by us
to meet any of these conditions would have a materially adverse effect upon us and may force us to reduce or curtail operations. No assurance
can be given that we can or will ever operate profitably.

We may not be able
to meet our future capital needs.

To date